1476.0000 -83.50 (-5.35%)
NSE Apr 04, 2025 11:56 AM
Volume: 345.2K
 

1476.00
-5.35%
Axis Direct
China remains a key geographic focus area for the company. Gland has received and launched one product this year. Recommendation: HOLD
Number of FII/FPI investors increased from 175 to 193 in Dec 2024 qtr.
More from Gland Pharma Ltd.
All earning calls
Investor presentations from Gland Pharma Ltd.
All investor presentations